CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi
收藏  |  浏览/下载:19/0  |  提交时间:2022/12/23
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie
收藏  |  浏览/下载:122/0  |  提交时间:2022/11/21
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载:17/0  |  提交时间:2022/12/22
Ratiometric co-delivery of hydroxychloroquine and calculated low-dose paclitaxel efficiently suppresses tumor growth in hepatocellular carcinoma mouse models in vivo 期刊论文
NANO TODAY, 2022, 卷号: 44
作者:  Wang, Wenbin;  Sun, Hui;  Gong, Yan;  Liu, Xiangsheng;  Liu, Xiao
收藏  |  浏览/下载:116/0  |  提交时间:2022/12/23
The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy 期刊论文
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 卷号: 9
作者:  Yuan, Meiqin;  Wang, Zeng;  Lv, Wangxia;  Pan, Hongming
收藏  |  浏览/下载:20/0  |  提交时间:2022/05/16


©版权所有 ©2017 CSpace - Powered by CSpace